电生理网络预测了在发作中对vigabatrin的临床反应
Junhyung Kim1, Min-Jee Kim2, Hyun-Jin Kim2
1Department of Neurosurgery, Asan Medical Center, Seoul, Republic of Korea.
Frontiers in neurology
|July 10, 2023
概括
脑电图 (EEG) 功能连接可以预测患有发作 (ES) 的婴儿对维加巴林治疗的反应. 较高的β连接率表明了积极的反应,而较低的α连接率表明了较差的结果.
科学领域:
- 神经科学是一个神经科学.
- 儿科神经学 儿科神经学
- 临床电生理学 临床电生理学
背景情况:
- 婴儿的发作 (ES) 是一个重大的临床挑战.
- 确定治疗反应的可靠预测因素对于优化患者护理至关重要.
研究的目的:
- 通过使用EEG功能连接来识别电子生理学标记,这些标记与ES婴儿对vigabatrin治疗的临床反应相关.
- 探索EEG功能连接模式和婴儿的治疗结果之间的关系.
主要方法:
- 对ES患者和年龄相匹配的健康对照进行描述性分析.
- 脑电图 (EEG) 在间歇性睡眠状态期间获取数据.
- 权衡阶段滞后指数 (wPLI) 分析,以评估跨频率和空间域的功能连接性.
主要成果:
- 与对照组相比,患有ES的婴儿表现出较高的三角形和三角形功率.
- 与对照组相比,ES受试者表现出更高的全局功能连接 (wPLI).
- 受益于治疗的响应者具有更高的β连接性 (平行尾区域);较差的响应者具有较低的α连接性 (额头区域).
- 结构异常与功能连接性降低相关,这表明保存完整性预测了更好的vigabatrin反应.
结论:
- 脑电图功能连接性分析显示,它有望预测ES婴儿早期治疗反应.
- 特定的连接模式 (β和α) 可能作为维加巴林疗效的生物标志物.
- 保持大脑的结构和功能完整性与ES患者治疗vigabatrin的良好结果有关.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
349
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
349
Antiepileptic Drugs: GABAergic Pathway Potentiators
467
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
467
Seizures: Classification
426
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
426
Antiepileptic Drugs: Potassium Channel Activators
215
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
215
Arteries of the Lower Limbs
215
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
215
Antiepileptic Drugs: Glutamate Antagonists
427
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
427


